CHF249.50
0.36%
SIX Swiss Exchange, Jun 28, 05:30 pm CET
ISIN
CH0012032048
Symbol
ROG
Index
Sector
Industry

Roche Share price

CHF249.50
+20.70 9.05% 1M
+7.05 2.91% 6M
+5.00 2.05% YTD
-25.25 9.19% 1Y
-98.55 28.31% 3Y
-25.15 9.16% 5Y
-15.00 5.67% 10Y
SIX Swiss Exchange, Closing price Fri, Jun 28 2024
ISIN
CH0012032048
Symbol
ROG
Index
Sector
Industry

Key figures

Market capitalization CHF198.91b
Enterprise Value CHF223.13b
PER (TTM) P/E ratio 17.32
EV/FCF (TTM) EV/FCF 18.99
EV/Sales (TTM) EV/Sales 3.80
P/S ratio (TTM) P/S ratio 3.39
P/B ratio (TTM) P/B ratio 6.79
Dividend yield 3.85%
Last dividend (FY23) CHF9.60
Sales growth (TTM) Sales growth -7.21%
Turnover (TTM) Turnover CHF58.72b
EBIT (operating result TTM) EBIT CHF16.35b
Free cash flow (TTM) Free cash flow CHF11.75b
EPS (TTM) EPS CHF14.40
P/E ratio expected 15.09
P/S ratio expected 3.26
EV/Sales expected 3.66
Show more

Register now for free to activate an alarm for the Roche share.

Activate alerts on the share price, dividend yield, valuation (e.g. P/E ratio or EV/sales) or strategy scores and sit back and relax.

Roche Share analysis

Analyst opinions

23 Analysts have issued a Roche forecast:

8x Buy
35%
11x Hold
48%
4x Sell
17%

Analyst opinions

23 Analysts have issued a Roche forecast:

Buy
35%
Hold
48%
Sell
17%

Financial data from Roche

Profit and loss account P&L | Balance sheet | Cash flow


TTM Annually
Dec '23
+/-
%
58,716 58,716
7% 7%
100%
- Direct costs 15,818 15,818
16% 16%
27%
42,898 42,898
3% 3%
73%
- Selling and administrative expenses 9,844 9,844
17% 17%
17%
- Research and development costs 13,231 13,231
6% 6%
23%
19,823 19,823
10% 10%
34%
- Depreciation and amortization 3,474 3,474
9% 9%
6%
EBIT (operating result) EBIT 16,349 16,349
10% 10%
28%
Net profit 11,498 11,498
7% 7%
20%

Figures in millions CHF.

Don't miss a thing! We will send you all news about the Roche share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Roche Share News

Neutral
GlobeNewsWire
3 days ago
Basel, 28 June 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the extension of the Vabysmo® (faricimab) marketing authorisation to include the treatment of visual impairment due to macular edema secondary to retinal vein occlusion (RVO). A final decision regar...
Neutral
GlobeNewsWire
3 days ago
Basel, 28 June 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for PiaSky® (crovalimab) for the treatment of paroxysmal nocturnal haemoglobinuria (PNH). The CHMP has recommended PiaSky, a novel recycling monoclonal antibody that inhibits the complement protei...
Neutral
GlobeNewsWire
4 days ago
Basel, 27 June 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the World Health Organization (WHO) has awarded the cobas® HPV test prequalification designations for use on the cobas® 5800 system and for self-collected samples on the cobas® 5800, 6800 and 8800 systems. These new prequalification designations come just one month after the U.S. Food and Drug Administration approved ...
More Roche News

Company profile

Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Head office Switzerland
CEO Thomas Schinecker
Employees 103,605
Founded 1896
Website www.roche.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now